Abstract:Motivation: Mapping the antigenic and genetic evolution pathways of influenza A is of critical importance in the vaccine development and drug design of influenza virus. In this article, we have analyzed more than 4000 A/H3N2 hemagglutinin (HA) sequences from 1968 to 2008 to model the evolutionary path of the influenza virus, which allows us to predict its future potential drifts with specific mutations. Results: The mutual information (MI) method was used to design a site transition network (STN) for each amino acid site in the A/H3N2 HA sequence. The STN network indicates that most of the dynamic interactions are positioned around the epitopes and the receptor binding domain regions, with strong preferences in both the mutation sites and amino acid types being mutated to. The network also shows that antigenic changes accumulate over time, with occasional large changes due to multiple co-occurring mutations at antigenic sites. Furthermore, the cluster analysis by subdividing the STN into several subnetworks reveals a more detailed view about the features of the antigenic change: the characteristic inner sites and the connecting inter-subnetwork sites are both responsible for the drifts. A novel five-step prediction algorithm based on the STN shows a reasonable accuracy in reproducing historical HA mutations. For example, our method can reproduce the 2003–2004 A/H3N2 mutations with ∼70% accuracy. The method also predicts seven possible mutations for the next antigenic drift in the coming 2009–2010 season. The STN approach also agrees well with the phylogenetic tree and antigenic maps based on HA inhibition assays. Availability: All code and data are available at http://ibi.zju.edu.cn/birdflu/ Contact: ruhongz@us.ibm.com Supplementary information: Supplementary data are available at Bioinformatics online.

Predicting Influenza H3N2 Vaccine Efficacy From Evolution of the Dominant Epitope

Prediction of Influenza B Vaccine Effectiveness from Sequence Data

Leveraging Pre-Vaccination Antibody Titers across Multiple Influenza H3N2 Variants to Forecast the Post-Vaccination Response

Predicting the Mutating Distribution at Antigenic Sites of the Influenza Virus.

A Novel Sequence-Based Antigenic Distance Measure for H1N1, with Application to Vaccine Effectiveness and the Selection of Vaccine Strains

Using A Mutual Information-Based Site Transition Network to Map the Genetic Evolution of Influenza A/H3n2 Virus

Quantifying influenza vaccine efficacy and antigenic distance

Generation and Characterization of Monoclonal Antibodies Against the Hemagglutinin of H3N2 Influenza A Viruses.

A sequence-based machine learning model for predicting antigenic distance for H3N2 influenza virus

Concepts and methods for predicting viral evolution

Predictive evolutionary modelling for influenza virus by site-based dynamics of mutations

Epitope analysis for influenza vaccine design

Prediction of influenza vaccine effectiveness for the influenza season 2017/18 in the US

VaxSeer: Selecting influenza vaccines through evolutionary and antigenicity models

Using Pathogen Genomics to Predict Antigenic Changes of Influenza H3N2 Virus

Computer-assisted vaccine design

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017

In-depth phylodynamics, evolutionary analysis and in silico predictions of universal epitopes of Influenza A subtypes and Influenza B viruses

Measures of population immunity can predict the dominant clade of influenza A (H3N2) in the 2017-2018 season and reveal age-associated differences in susceptibility and antibody-binding specificity